Latest Breaking News On - Gregg gilbert - Page 4 : comparemela.com
Bristol-Myers Squibb Company (NYSE:BMY) - Why This Bristol-Myers Squibb Stock Analyst Is Turning Bullish On The Pharma Company s Pipeline
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Operator
Greetings, and welcome to the BioDelivery Sciences Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions]
It is now my pleasure to introduce your host, Ms. Terry Coelho, Executive Vice President and Chief Financial Officer. Thank you. Please go ahead.
Terry Coelho
Executive Vice President and Chief Financial Officer
Thank you, and good morning, everyone. Welcome to our fourth quarter 2020 earnings conference call. Leading the call today is Jeff Bailey, Chief Executive Officer. We are joined by Scott Plesha, President and Chief Commercial Officer. Following our prepared remarks, we will conduct a question-and-answer session. Earlier today BioDelivery Sciences issued a press release announcing its financial results for the fourth quarter and full year 2020. A copy of the release can be found on the Investor Relations page of the company s website.
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble.
Amneal Pharmaceuticals, Inc. (NYSE: AMRX)
Popular Searches
Operator
Good morning and welcome to the Amneal Pharmaceuticals Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Tasos Konidaris, Executive Vice President and Chief Financial Officer. Please go ahead.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter and Full Year 2020 Coherus BioSciences Conference Call. [Operator Instructions]
I would now like to turn the conference over to your host today, Mr. McDavid Stilwell. Sir, please go ahead.
McDavid Stilwell
Executive Vice President, Corporate Development, Investor Relations, and Financial Strategy
Thank you. Good afternoon, everyone, and thank you for joining us. We issued a press release earlier announcing our 2020 fiscal year and fourth quarter results and the release can be found on the Coherus BioSciences website. Today s call includes forward-looking statements regarding Coherus current expectations. These statements include, but are not limited to, our ability to advance our biosimilar and immuno-oncology product candidates through development and registration.
Jazz Pharmaceuticals PLC (JAZZ) Q4 2020 Earnings Call Transcript
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
vimarsana © 2020. All Rights Reserved.